Smith+Nephew recently signed an exclusive U.S. distribution agreement with RMR Ortho to add the A’TOMIC nitinol fixation system to its Trauma, Foot & Ankle and Hand & Wrist portfolio.

RMR Ortho’s system uses proprietary manufacturing methods and nitinol’s unique properties for compressive fixation implants that have a wide bridge with barbed, round legs that match drill holes. The system was designed to achieve fusion, fracture, and osteotomy site stability though high strength and active compression.

“This partnership with RMR Ortho strengthens Smith+Nephew’s fixation portfolio by adding a dynamic compression fixation solution that complements our existing technologies,” said Scott Gunn, VP of U.S. Marketing, Trauma, Extremities, and Shoulder at Smith+Nephew. “The A’TOMIC Nitinol Fixation System expands our ability to participate in high-frequency fracture and arthrodesis procedures while leveraging our established Extremities and Trauma sales channel to deepen surgeon engagement. This collaboration reflects our disciplined approach to portfolio expansion and our continued focus on driving sustainable growth.”

“Partnering with Smith+Nephew represents an important step forward for RMR Ortho as we continue to expand access to the A’TOMIC Nitinol Fixation System across key U.S. territories,” added Joe Ritz, CEO of RMR Ortho. “Smith+Nephew’s established presence in orthopedic extremities and trauma, deep surgeon relationships, and commercial scale make them a strong partner as we work to deliver reliable, continuously compressive fixation solutions to surgeons, hospitals, and patients.”

Ealier this month, the company began teaming up with Karl Storz North America to align its sports medicine portfolio with Karl Storz’s visualization, video management, and OR integration technologies.